The Effect of Fullerenol Combined with Cisplatin on the Proliferation of Cervical Cancer HeLa Cells
- 1 Medical College, Qingdao University, Qingdao, China
- 2 Department of Radiotherapy Oncology, Qilu Hospital of Shandong University (Qingdao), Qingdao, China
Abstract
This study aimed to investigate the effect of fullerenol combined with cisplatin on the proliferation of cervical cancer HeLa cells in order to provide new ideas and laboratory theoretical basis for the clinical treatment of cervical cancer. Cervical cancer cell line HeLa cells in vitro were treated with different concentrations of fullerenol, different concentrations of cisplatin, and different concentrations of fullerenol combined with cisplatin, after 24 h, 48 h, 72 h, microscope changes in cell morphology; MTT assay was used to determine the effect of drugs on the proliferation of HeLa cells. Fullerenol and cisplatin alone can inhibit the proliferation of HeLa cells in a dose-dependent and time-dependent manner; compared with cisplatin alone, different concentrations of fullerenol combined with cisplatin significantly increased the apoptosis rate of HeLa cells (P < 0.05). The inhibition of fullerenol combined with cisplatin on HeLa cells in vitro is more significant, resulting in a stronger anti-cancer effect.
- Ying, Q., Xia, Q.M., Zheng, R.S., Zhang, S.W. and Chen, W.Q. (2013) China Cervical Cancer Incidence and Mortality in 2009. Chinese Journal of Cancer, No. 8, 612-616. (In Chinese)
- Duan, Y.C. and Hu, P. (2007) Progress in the Treatment of Cervical Cancer. Foreign Medical Sciences, No. 2, 137-139. (In Chinese)
- Sardi, J.E., Boixadera, M.A. and Sardi, J.J. (2005) Neoadjuvant Chemotherapy in Cervical Cancer: A New Trend. Current Opinion in Obstetrics and Gynecology, 17, 43-47. http://dx.doi.org/10.1097/00001703-200502000-00008
- Miglietta, L., Franzone, P., Centurioni, M.G., et al. (2006) Aphase Trial with Cisplatin-Paclitaxel Cytotoxic Treatment and Concurrent External and Endocavitary Radiation Therapy in Locally Advanced or Recurrent Cervical Cancer. Oncology, 70, 19-24. http://dx.doi.org/10.1159/000091182
- DuPont, N.C. and Monk, B.J. (2006) Chemotherapy in the Management of Cervical Carcinoma. Clinical Advances in Hematology & Oncology, 4, 279.
- Huang, M.N., Wu, L.Y. and Gao, J.Z. (2004) Cervical Cancer Progression. Chemoradiotherapy Magazine, 2, 320-322. (In Chinese)
- Yin, W.B., Yu, Z.H., Xu, G.Z., et al. (2008) Cancer Radiation Therapy. 4th Edition, China Union Medical University Press, Beijing, 1350-1372. (In Chinese)
- Yang, W.H., Chen, D.B. and Wang, X.M. (2004) Biology and Biomedical Research Applications of Fullerenes and Fullerenols. Progress in Pharmaceutical Sciences (Chinese), 28, 243-246.
- Chiang, L.Y., Lu, F.J. and Lin, J.T. (1995) Free Radical Scavenging Activity of Water-Soluble Fullerenols. Journal of the Chemical Society, Chemical Communications, 12, 1283-1284. http://dx.doi.org/10.1039/c39950001283
- Liu, F.X. and Song, Y. (2010) Effect SJAMP on Apoptosis of HeLa and Bax, Bcl-2 Gene Expression. Practical Journal of Medicine, 26, 2089-2091.
- Liu Y.Q., Xing, H., Han, X.B., et al. (2006) Cisplatin-Induced Apoptosis in HeLa Cells and Its Mechanism of Action. Chinese Journal of Clinical Oncology, 33, 1-4. (In Chinese)
- Maeda, R., Noiri, E., Isobe, H., et al. (2008) A Water-Solube Fullerene Vesicle Alleviates Angiotensin II-Induced Oxidative Stress in Human Unbilical Venous Endothelial Cells. Hypertension Research, 31, 141-151. http://dx.doi.org/10.1291/hypres.31.141
- Yang, W.J. (2008) Role of Nanomaterials in the Treatment of Cancer Research. Thesis, University of Science and Technology of China, Hefei. (In Chinese)